SOMATROPIN INJECTION (NORDITROPIN FLEXPRO PEN) 15MG
Somatropin, or rh-GH, is a pure form of recombinant growth hormone produced by either mammalian or Escherichia coli bacteria. The pituitary produces endogenous human growth hormone (hGH). In 1956, the first growth hormone was extracted, and its structure was discovered in 1972. Growth hormone (GH) was previously generated from human cadavers prior to 1985; however, this practice was discontinued due to Creutzfeldt-Jakob virus contamination of the product. Somatropin is licensed for use in adults with short bowel syndrome, growth hormone deficit (GHD), growth failure, or short stature, as well as cachexia and AIDS wasting. In studies for the treatment of HIV-associated adipose redistribution syndrome (HARS), somatropin has been shown to reduce visceral adipose tissue, according to limited short-term evidence. There are numerous somatropin medications available, each with unique indications and dose guidelines. It is important to choose products carefully because they could not be interchangeable. The FDA initially authorized somatropin in 1987.
| Pharmacy | Empower |
|---|---|
| Instructions | Once a Norditropin pen is in use, the pen should be stored in the refrigerator (2 to 8 °C; 36 to 46 °F), and used within 4 weeks. Alternatively, the Norditropin pens may be stored in the pen at room temperatures, no higher than 25°C (77°F), for up to 3 weeks. NovoFine needles are recommended for administration. Wipe the stopper on the needle thread with rubbing alcohol to prevent contamination. Do not use a reconstituted solution if cloudy or contains particulate matter. Before use, store under refrigeration at 2 to 8°C (36 to 46°F). Keep all medicines out of the reach of children. Throw away any unused medicine after the beyond-use date. Do not flush unused medications or pour them down a sink or drain. |